Iclusig 15 MG

Ended Awarded

Contract number
36C24525N0619
Awardee
Awarding agency
Obligated
$14,197

Award facts

Contract value 100% obligated
$14,197.39 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Earth City, MO 63045, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $14,197.39, is for the delivery of ICLUSIG 15 MG, a specialty oncology medication, to VA medical facilities and Veterans Integrated Service Networks (VISNs) across multiple regions.

The contract was awarded under the VA's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs, which provides a streamlined procurement mechanism for the VA to obtain critical medical treatments for veterans. Takeda Pharmaceuticals America, Inc. holds a $123.5 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center under this GSA Schedule, enabling the VA to efficiently order ICLUSIG and potentially other oncology medications as needed to support its nationwide healthcare network. The contract has a completion date of May 8, 2025 and does not have a small business set-aside designation.

Quick answers

Who was awarded contract 36C24525N0619?

36C24525N0619 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on May 2, 2025.

How much is contract 36C24525N0619 worth?

The government has obligated $14,197 on 36C24525N0619.

Is contract 36C24525N0619 an order under another contract?

Yes. 36C24525N0619 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24525N0619 competed?

The extent of competition for 36C24525N0619 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award